Suppr超能文献

莱茵衣藻α1-微管蛋白基因的突变赋予了对抗微管除草剂的抗性。

A mutation in the alpha 1-tubulin gene of Chlamydomonas reinhardtii confers resistance to anti-microtubule herbicides.

作者信息

James S W, Silflow C D, Stroom P, Lefebvre P A

机构信息

Department of Genetics and Cell Biology, University of Minnesota, St. Paul 55108-1095.

出版信息

J Cell Sci. 1993 Sep;106 ( Pt 1):209-18. doi: 10.1242/jcs.106.1.209.

Abstract

A mutation in the alpha 1-tubulin gene of Chlamydomonas reinhardtii was isolated by using the amiprophos-methyl-resistant mutation apm1-18 as a background to select new mutants that showed increased resistance to the drug. The upA12 mutation caused twofold resistance to amiprophos-methyl and oryzalin, and twofold hypersensitivity to the microtubule-stabilizing drug taxol, suggesting that the mutation enhanced microtubule stability. The resistance mutation was semi-dominant and mapped to the same interval on linkage group III as the alpha 1-tubulin gene. Two-dimensional gel immunoblots of proteins in the mutant cells revealed two electrophoretically altered alpha-tubulin isoforms, one of which was acetylated and incorporated into microtubules in the axoneme. The mutant isoforms co-segregated with the drug-resistance phenotypes when mutant upA12 was backcrossed to wild-type cells. Two-dimensional gel analysis of in vitro translation products showed that the non-acetylated variant alpha-tubulin was a primary gene product. DNA sequence analysis of the alpha 1-tubulin genes from mutant and wild-type cells revealed a single missense mutation, which predicted a change in codon 24 from tyrosine in wild type to histidine in mutant upA12. This alteration in the predicted amino acid sequence corroborated the approximately +1 basic charge shift observed for the variant alpha-tubulins. The mutant allele of the alpha 1-tubulin gene was designated tua1-1.

摘要

以抗甲基胺草磷突变体apm1-18为背景,分离莱茵衣藻α1-微管蛋白基因的一个突变体,以筛选对该药物具有更高抗性的新突变体。upA12突变使细胞对甲基胺草磷和oryzalin产生了两倍的抗性,而对微管稳定药物紫杉醇则表现出两倍的超敏性,这表明该突变增强了微管的稳定性。该抗性突变是半显性的,并且与α1-微管蛋白基因定位在连锁群III的同一区间。突变细胞中蛋白质的二维凝胶免疫印迹显示出两种电泳改变的α-微管蛋白异构体,其中一种被乙酰化并整合到轴丝中的微管中。当突变体upA12与野生型细胞回交时,突变体异构体与药物抗性表型共分离。体外翻译产物的二维凝胶分析表明,未乙酰化的变体α-微管蛋白是主要基因产物。对突变体和野生型细胞的α1-微管蛋白基因进行DNA序列分析,发现了一个单一的错义突变,该突变预测密码子24从野生型的酪氨酸变为突变体upA12中的组氨酸。预测氨基酸序列的这种改变证实了变体α-微管蛋白观察到的约+1的碱性电荷偏移。α1-微管蛋白基因的突变等位基因被命名为tua1-1。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验